Letairis

Gilead to pay $97 million to settle U.S. kickback probe
Reuters
Wed, 09/23/20 - 11:22 pm
Gilead Sciences
Letairis
Medicare
kickbacks
Gilead cuts cardiopulmonary sales reps
BioCentury
Wed, 04/10/19 - 11:44 pm
Gilead Sciences
layoffs
generics
Letairis
Ranexa
Gilead Sciences Letairis Wins FDA Nod For PAH: Stock To Recover Soon
Bidness, ETC
Tue, 10/6/15 - 09:51 am
PAH
pulmonary arterial hypertension
FDA
Gilead Sciences
Letairis
Actavis seeking FDA Approval to market generic version of Gilead drug
Marketwatch
Fri, 04/3/15 - 10:35 am
Actavis
FDA
generics
Gilead Sciences
Letairis
PAH
GSK and Gilead’s combination therapy: positive results in PAH
Pharmaphorum
Tue, 09/9/14 - 10:36 am
GSK
Gilead Sciences
PAH
pulmonary arterial hypertension
Letairis
Adcirca
Actelion’s Lung Drug May Face Study Against Gilead Rival
Bloomberg
Wed, 02/12/14 - 09:50 am
Actelion
Gilead Sciences
Opsumit
Letairis
PAH
pulmonary arterial hypertension
Gilead gets subpoena from Justice Department
MarketWatch
Sat, 06/11/11 - 10:23 am
Gilead Sciences
Atripla
Emtriva
Hepsera
Letairis
Truvada
Viread
Gilead Sciences removes warning for Letairis
Yahoo/AP
Sat, 03/5/11 - 12:05 pm
Gilead Sciences
Letairis